Journal article
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis
Current opinion in allergy and clinical immunology, v 24(5), pp 380-389
01 Oct 2024
PMID: 39079155
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Purpose of review
Allergic conjunctivitis is characterized by the development of pathophysiological changes to the ocular surface, which occurs when pro-allergic and pro-inflammatory mediators interact with their cognate receptors expressed on immune and nonimmune cells. Traditional treatments with antihistamines and corticosteroids provide relief, but there is a need for more efficacious and tolerable long-term therapy with a better safety profile. This article aims to provide an overview of the mode of action and clinical application of agonist therapies targeting glucocorticoid, melanocortin, and toll-like receptors, as well as antagonist therapies targeting cytokine, chemokine, integrin, and histamine receptors.
Recent findings
There has been considerable advancement in immunology and pharmacology, as well as a greater understanding of the cellular and molecular mechanisms of allergic conjunctivitis. Recent research advancing therapy for allergic conjunctivitis has focused on developing synthetic molecules and biologics that can interfere with the process of the allergic immune reaction.
Summary
This review discusses novel therapeutic receptors being explored agonistically or antagonistically to develop alternative treatment options for allergic conjunctivitis. These novel approaches hold promise for improving the management of allergic eye diseases, offering patients hope for more effective and safer treatment options in the future.
Metrics
Details
- Title
- Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis
- Creators
- Sampson L. Abu - Salus UniversityNavpreet K. Hehar - Drexel UniversityDeGaulle I. Chigbu - Drexel University
- Publication Details
- Current opinion in allergy and clinical immunology, v 24(5), pp 380-389
- Publisher
- Lippincott Williams & Wilkins
- Number of pages
- 10
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- The Eye Institute (TEI) [Historical]; Pennsylvania College of Optometry (PCO)
- Web of Science ID
- WOS:001302528100018
- Scopus ID
- 2-s2.0-85200396737
- Other Identifier
- 991022019603704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Allergy
- Immunology